Better Recovery Story Buy: Novavax vs. Teladoc
Everybody loves a good recovery story. You can get in on a promising company, with a potentially bright future ahead, but at a terrific price. And that means you could win big each time this player reports positive news and makes progress toward its goals. Of course, this is what we all would like to happen, but sometimes recovery doesn't go as planned. So, before betting on these sorts of stories, consider your appetite for risk. Even if you're OK with risk, make these recovery-story bets part of a diversified portfolio.
Now, let's get ready to do some recovery-story investing. Today, two recovery stories look particularly interesting, and if everything works out for these companies, their shares could deliver significant gains. I'm talking about (NASDAQ: NVAX) and Teladoc Health (NYSE: TDOC). The shares have dropped more than 90% from their peak in 2021. Which makes the better recovery-story buy right now? Let's find out.
Image source: Getty Images.
Source Fool.com
Novavax Inc. Stock
Based on 3 Buy predictions and 2 Sell predictions the sentiment towards Novavax Inc. is rather balanced.
With a target price of 12 € there is potential for a 215.08% increase which would mean more than doubling the current price of 3.81 € for Novavax Inc..
